Development of a shielding device for radiotherapy of breast cancer-bearing mice
DOI:
https://doi.org/10.15392/bjrs.v8i1A.1164Palavras-chave:
ionizing radiation, lead, thermoluminescent dosimetersResumo
Breast cancer is the fifth most common cause of death worldwide. Currently, one of the standard treatments for breast cancer is radiation therapy (RT). On the other hand, mouse models have been used in pre-clinical studies for breast cancer RT, requiring dedicated shielding to exposure the breast region. In this work, we considered the values of the lead attenuation coefficient and the tenth reducing layer for a 60Co irradiator and developed a lead shielding device for breast cancer-bearing mice to be exposed to localized breast RT. Five-kg of lead were exposed to temperature of 340ºC and inserted into an aluminum mold previously adjusted to the dimensions of the device. After solidification, the device was shaped into a cylinder with dimension of 14 x 15 x 7 cm (height x width x thickness, respectively). A round cut-out for breast exposure of 1 cm in diameter was made at 5 cm from the basis of the device. For shielding device validation, we performed calibrations to establish a dose of 10 Gy in the target. Fifteen CaSO4:Dy thermoluminescent dosimeters were distributed along a 50 mL conical tube to simulate the mouse position inside the shielding. The shielding device was placed at a fixed distance of 10 cm from the target for optimal exposure time. After irradiation, the dosimeters were read on a thermoluminescent reader. According to our results, we were able to develop a body-shielding device that assured the required dose for RT of breast cancer in mice.
Downloads
Referências
WHO- World Health Organization. Cancer. Available at <https://www.who.int/news-room/fact-sheets/detail/cancer >. Last accessed : 26.Jul. 2019.
AKRAM, M.; IQBAL, M.; DANIYAL, M. et al. Awareness and current knowledge of breast cancer. Biol Res, v. 50, n. 1, p. 33, 2017.
KRUG, D.; BAUMANN, R.; BUDACH, W. et al. Current controversies in radiotherapy for breast cancer. Radiat Oncol, v. 12, n. 1, p. 25, 2017.
MANNING, H. C.; BUCK, J. R.; COOK, R. S. Mouse models of breast cancer: platforms for discovering precision imaging diagnostics and future cancer medicine. J Nucl Med, v. 57, n. Suppl 1, p. 60S-8S, 2016.
GIESE, A. P.; GUARNASCHELLI, J. G.; WARD, J. A. et al. Radioprotective effect of aminothiol PrC-210 on irradiated inner ear of guinea pig. PLoS One, v. 10, n. 11, p. e0143606, 2015.
MIBIORESEARCH. Utilization of radiation in the preclinical oncology setting - MI Bioresearch. Disponível em: < https://www.mibioresearch.com/knowledge-center/utilization-radiation-preclinical-oncology-setting/>. Last accessed : 12 Sept. 2019.
OLIVEIRA, M. L. D.; MAIA, A. F.; NASCIMENTO, N. C. E. S. et al. Influence of thermoluminescent dosimeters energy dependence on the measurement of entrance skin dose in radiographic procedures. Radiol Bras, v. 43, n. 2, p. 5, 2019.
MCALISTER, D. R. Gamma ray attenuation properties of common shielding materials. Available at <https://www.eichrom.com/wp-content/uploads/2018/02/Gamma-Ray-Attenuation-White-Paper-by-D-M-rev-6-1-002.pdf>. Last accessed : 12 Sept. 2019.
PORTAL, G. Review of the principal materials available for thermoluminescent dosimetry. Radiat Prot Dosimetry, v. 17, n. 1-4, p. 351-357, 1986.
LAKSHMANAN, A. Development and application of solid forms of CaSO4:Dy thermoluminescent dosemeters in radiation protection dosimetry-A review. Radiat Prot Dosimetry, v. 181, n. 2, p. 57-99, 2018.
CAMPOS, L. L.; LIMA, M. F. Dosimetric properties of CaSO4:Dy teflon pellets produced at IPEN. Radiat Prot Dosimetry, v. 14, n. 4, p. 333-335, 1986.
HUBBELL, J. H. Photon mass attenuation and mass energy-absorption coefficients for H, C, N, O, Ar, and seven mixtures from 0.1 KeV to 20 MeV. Radiat Res, v. 70, n. 1, p. 58-81, 1977.
SOHN, J. W.; MACKLIS, R.; SUH, J. K. et al. A mobile shield to reduce scatter radiation to the contralateral breast during radiotherapy for breast cancer: preclinical results. Int J Radiat Oncol Biol Phys, v. 43, n. 5, p. 1037-41, 1999.
GRASSO, C.; FABRE, M. S.; COLLIS, S. V. et al. Pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model. Front Oncol, v. 4, p. 356, 2014.
KAPLON, R.; HADZIAHMETOVIC, M.; SOMMERFELD, J. et al. The application of radiation therapy to the Pediatric Preclinical Testing Program (PPTP): results of a pilot study in rhabdomyosarcoma. Pediatr Blood Cancer, v. 60, n. 3, p. 377-382, 2013.
Downloads
Publicado
Edição
Seção
Categorias
Licença
Direitos autorais (c) 2020 Brazilian Journal of Radiation Sciences
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Declaro que o presente artigo é original, não tendo sido submetido à publicação em qualquer outro periódico nacional ou internacional, quer seja em parte ou em sua totalidade. Declaro, ainda, que uma vez publicado na revista Brazilian Journal of Radiation Sciences, editada pela Sociedade Brasileira de Proteção Radiológica, o mesmo jamais será submetido por mim ou por qualquer um dos demais co-autores a qualquer outro periódico. Através deste instrumento, em meu nome e em nome dos demais co-autores, porventura existentes, cedo os direitos autorais do referido artigo à Sociedade Brasileira de Proteção Radiológica, que está autorizada a publicá-lo em meio impresso, digital, ou outro existente, sem retribuição financeira para os autores.
Licença
Os artigos do BJRS são licenciados sob uma Creative Commons Atribuição 4.0 Licença Internacional, que permite o uso, compartilhamento, adaptação, distribuição e reprodução em qualquer meio ou formato, desde que você dê o devido crédito ao (s) autor (es) original (is) e à fonte, forneça um link para a licença Creative Commons, e indique se mudanças foram feitas. As imagens ou outro material de terceiros neste artigo estão incluídos na licença Creative Commons do artigo, a menos que indicado de outra forma em uma linha de crédito para o material. Se o material não estiver incluído no licença Creative Commons do artigo e seu uso pretendido não é permitido por regulamentação legal ou excede o uso permitido, você precisará obter permissão diretamente do detentor dos direitos autorais. Para visualizar uma cópia desta licença, visite http://creativecommons.org/licenses/by/4.0/
